All members have the option of attending our various HTC-centric events which include:
Date: Tuesday, March 5, 2024 Time: 1:00pm - 2:00pm ET TITLE: Advocating for Access to Behavioral Health Treatment for the Bleeding Disorders Community WEBINAR OBJECTIVE: This presentation will educate HTC Read the full article...
Date: Thursday, March 14, 2024 Time: 1:00pm - 2:00pm ET TITLE: Exploring the Science and Possibilities of Gene Therapy in Hemophilia WEBINAR OVERVIEW: By attending this webinar, you will discover Read the full article...
Date: Tuesday, May 7, 2024 Time: 2:00pm - 3:00pm ET TITLE: Reinforcing 10+ years of clinical trial experience with a subcutaneous prophylaxis treatment, including the latest data in infants WEBINAR Read the full article...
Date: Tuesday, May 14, 2024 Time: 2:00pm - 3:00pm ET TITLE: Hemophilia Alliance Network Services/Emerging Therapy Solutions A Gene Therapy Payer Contract WEBINAR DESCRIPTION: The past twelve to eighteen months Read the full article...
Date: Wednesday, June 5, 2024 Time: 1:00pm - 2:00pm ET TOPIC: Clinical review of the Jivi® PROTECT VIII Trial and insights from HEM-POWR: A Real-World Evidence (RWE) Study of Jivi® Read the full article...
Date: Thursday, June 20, 2024 Time: 2:00pm - 3:00pm ET Title: Practice Considerations for ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) Objectives: Review coverage and typical prior authorization criteria for ROCTAVIAN Review considerations and Read the full article...
Date: Tuesday, June 25, 2024 Time: 1:00pm - 2:00pm ET Title: Wilate Prophylaxis in VWD – Results from the WIL-31 Study Objectives: 1) Understand the bleeding symptoms experienced by folks Read the full article...
Date: Thursday, July 11, 2024 Time: 1:00pm - 2:00pm ET Title: Understanding the difference between Copay Accumulators, Copay Maximizers, and Alternative Funding Programs. Objectives: In this comprehensive session, attendees will Read the full article...
Date: Tuesday, July 16, 2024 Time: 2:00pm - 3:00pm ET Discussion Topic: VWD Case-Based Experience Description: Join our expert, Dr. Maissaa Janbain, MD, for an interactive discussion about managing patients Read the full article...
Date: Wednesday, August 21, 2024 Time: 1:00pm - 2:00pm ET Title: Hemophilia Alliance Genetic Testing Program Hemophilia Alliance has introduced a new Genetic Testing Program as of August 1, Read the full article...
Date: Thursday, October 17, 2024 Time: 12:00pm - 1:00pm ET Topic: Shining a Spotlight: The Journey to Optimize Care in Women and Girls with Hemophilia A Objectives: Shine a light Read the full article...
Date: Wednesday, October 30, 2024 Time: 1:00pm - 2:00pm ET Title: Navigating The Enhanced Requirements Of DSCSA As A 340B Covered Entity Objectives: Review a brief history of the Drug Read the full article...
Date: Wednesday, November 6, 2024 Time: 2:00pm - 3:00pm ET (Updated Starting Time) Topic: Explore KOVALTRY® With Confidence Overview: Clinical Trial Results, Dosing and Pharmacokinetics of KOVALTRY® in adults, adolescents Read the full article...
Date: Thursday, November 21, 2024 Time: 2:00pm - 3:00pm ET Title: Health Equity Description: Please join Takeda for a webinar on Health Equity and how Takeda is making progress towards Read the full article...
Date: Wednesday, December 4, 2024 Time: 12:00pm - 1:00pm ET Topic: Real World Surgical Experiences with Altuviiio Description: This program will focus on sharing real-world experiences with Read the full article...
Date: Wednesday, December 18, 2024 Time: 1:00pm - 2:00pm ET Title: Unmet Needs in Current Hemophilia Care: From Burdens to Breakthroughs Description and Session Objectives: To Read the full article...
Date: Wednesday, February 19, 2025 Time: 1:00pm - 2:00pm ET TITLE: ROCTAVIAN: Improving Patient Outcomes - Latest Data & Support Initiatives OBJECTIVE: Join us for a webinar Read the full article...
Date: Wednesday, March 19th, 2025 Time: 12:00pm - 1:00pm ET WEBINAR TOPIC: Updates from Washington: Administration and Congressional Actions OBJECTIVE: The current status of government funding for fiscal year 2025. Read the full article...
Date: Thursday, March 20th, 2025 Time: 2:00pm - 3:00pm ET TITLE: Takeda FVIII Portfolio OBJECTIVE: Please join Takeda leadership to review Takeda FVIII Products & Resources Available. Read the full article...
Date: Thursday, April 3rd, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with Read the full article...
